Irene Bagnasco

April 16, 2026

Real‐world effectiveness of highly purified cannabidiol in epilepsy associated with 15q11.2‐q13.1 duplication and deletion syndromes: A multicenter study

Abstract Plain Language Summary: Epilepsy secondary to 15q11.2‐q13.1 duplication or deletion syndromes (15q‐DDS) is often severe, making daily life difficult…

June 21, 2025

Is highly purified cannabidiol a treatment opportunity for drug‐resistant epilepsy in subjects with typical Rett syndrome and CDKL5 deficiency disorder?

Abstract Objective: This study aimed to evaluate the efficacy and safety of adjunctive, highly purified Cannabidiol (Epidiolex®) in individuals with…